Pneumocystis Infection - Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Pneumocystis Infection - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Pneumocystis Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pneumocystis Infection and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Pneumocystis Infection Overview
  3. Therapeutics Development
  4. Pipeline Products for Pneumocystis Infection - Overview
  5. Pipeline Products for Pneumocystis Infection - Comparative Analysis
  6. Pneumocystis Infection - Therapeutics under Development by Companies
  7. Pneumocystis Infection - Therapeutics under Investigation by Universities/Institutes
  8. Pneumocystis Infection Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Pneumocystis Infection - Products under Development by Companies
  13. Pneumocystis Infection - Products under Investigation by Universities/Institutes
  14. Pneumocystis Infection - Companies Involved in Therapeutics Development
  • BioDiem Ltd
  • Matinas BioPharma Holdings, Inc.

For more information visit http://www.researchandmarkets.com/research/wjwf2q/pneumocystis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Respiratory Drugs, Infectious Diseases Drugs, Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Respiratory Drugs, Infectious Diseases Drugs, Infectious Diseases Drugs